MOMTAZEE JAMES C (CIK 1209181) reported 15 SEC Form 4 insider transactions across 2 companies over the past 18 months (most recent 2026-07-21). Recent activity: Buy ROIV (405 shares), Buy BBIO (3,990 shares), Buy ROIV (469 shares), Sell ROIV (94 shares), Buy ROIV (609 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-21 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 405 | $0 |
| 2026-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 3,990 | $0 |
| 2026-04-21 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 469 | $0 |
| 2026-04-21 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 94 | $2,804 |
| 2026-01-22 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 609 | $0 |
| 2026-01-22 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 122 | $2,804 |
| 2025-10-22 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 789 | $0 |
| 2025-10-22 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 158 | $2,803 |
| 2025-09-12 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 14,524 | $0 |
| 2025-09-12 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 3,282 | $45,193 |
| 2025-07-21 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 1,201 | $0 |
| 2025-07-21 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 241 | $2,808 |
| 2025-06-24 | BridgeBio Pharma, Inc. (BBIO) | Director | Buy | 6,589 | $0 |
| 2025-04-21 | Roivant Sciences Ltd. (ROIV) | Director | Buy | 1,379 | $0 |
| 2025-04-21 | Roivant Sciences Ltd. (ROIV) | Director | Sell | 276 | $2,801 |
Source: SEC Form 4 filings · as of 2026-07-21